Raymond de Vre - 11 Jun 2026 Form 4 Insider Report for CODEXIS, INC. (CDXS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Jun 2026, 20:19:27 UTC
Prior SEC filing
13 Nov 2025
Next SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Georgia Erbez, as Attorney-in-Fact for Raymond De Vre

Key filing fact

Raymond de Vre filed Form 4 for CODEXIS, INC. (CDXS) on 11 Jun 2026.

Key facts

  • This page summarizes Raymond de Vre's Form 4 filing for CODEXIS, INC. (CDXS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Jun 2026, 20:19.

Change

  • Previous filing in this sequence was filed on 13 Nov 2025.
  • Current net transaction value: -$6,174.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002043287 Primary reporting owner

De Vre Raymond

Relationship
Director
Address
200 PENOBSCOT DRIVE, REDWOOD CITY
Signature
/s/ Georgia Erbez, as Attorney-in-Fact for Raymond De Vre
Signature date
11 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDXS transaction

Common Stock

Sale

Transaction value
$6,174
Shares
-2,605
Change %
-3%
Price
$2.37
Shares after
84,811
Date
11 Jun 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sale reported on this Form 4 was effected to cover tax liability incurred due to the vesting and release of Restricted Stock Units ("RSUs") held by the Reporting Person.

Footnote F2

Includes 31,897 RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .